Highlights AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-06 pm EDT			5-day change	1st Jan Change
75.76 ^USD	-0.77%		+0.37%	+12.49%

May. 06	Cellectis: alliance with AstraZeneca finalized	CF
May. 06	Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cellectis: alliance with AstraZeneca finalized	May. 06	CF
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca	May. 06	MT
AstraZeneca: equity investment in Cellectis	May. 06	CF
AstraZeneca completes collaboration and investment deal with Cellectis	May. 06	AN
AstraZeneca Secures 44% Stake in French Biotech Cellectis	May. 06	MT
Angle shares up on assay development deal with AstraZeneca	May. 03	AN
Angle shares up on assay development deal with AstraZenaca	May. 03	AN
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca	May. 03	MT
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	May. 03	AN
InterContinental Hotels makes first-quarter progress	May. 03	AN
AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial	May. 02	MT
AstraZeneca: research into respiratory diseases	May. 02	CF
AstraZeneca Announces Positive High-Level Results from an Interim Analysis of the Echo Phase III Trial	May. 02	CI
AstraZeneca PLC Announces Positive High-Level Results from an Interim Analysis of the Echo Phase III Trial	May. 02	CI
AstraZeneca: encouraging results in lymphoma	May. 02	CF
AstraZeneca notes positive trial results for Calquence treatment	May. 02	AN
AstraZeneca's Blood Cancer Combo Extends Progression-free Survival in Late-stage Study	May. 02	MT
AstraZeneca PLC Announces Calquence combination improved PFS in 1L MCL	May. 02	CI
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	Apr. 30	MT
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	Apr. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT